176 related articles for article (PubMed ID: 23323755)
1. MPP(+) -dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons.
Masi A; Narducci R; Landucci E; Moroni F; Mannaioni G
Br J Pharmacol; 2013 May; 169(1):130-42. PubMed ID: 23323755
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Parkinsonian toxin MPP+ on electrophysiological properties of nigral dopaminergic neurons.
Yee AG; Lee SM; Hunter MR; Glass M; Freestone PS; Lipski J
Neurotoxicology; 2014 Dec; 45():1-11. PubMed ID: 25193392
[TBL] [Abstract][Full Text] [Related]
3. Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons.
Masi A; Narducci R; Resta F; Carbone C; Kobayashi K; Mannaioni G
Eur J Neurosci; 2015 Nov; 42(9):2699-706. PubMed ID: 26354486
[TBL] [Abstract][Full Text] [Related]
4. Effects of ghrelin on the electrical activities of substantia nigra dopaminergic neurons treated with MPP
Chang X; Ma Z; Shi L; Xie J
Neurochem Int; 2020 Sep; 138():104780. PubMed ID: 32569790
[TBL] [Abstract][Full Text] [Related]
5. Dual effects of L-DOPA on nigral dopaminergic neurons.
Guatteo E; Yee A; McKearney J; Cucchiaroni ML; Armogida M; Berretta N; Mercuri NB; Lipski J
Exp Neurol; 2013 Sep; 247():582-94. PubMed ID: 23481547
[TBL] [Abstract][Full Text] [Related]
6. Paraquat inhibits postsynaptic AMPA receptors on dopaminergic neurons in the substantia nigra pars compacta.
Lee CY; Lee CH; Shih CC; Liou HH
Biochem Pharmacol; 2008 Oct; 76(9):1155-64. PubMed ID: 18761327
[TBL] [Abstract][Full Text] [Related]
7. High dendritic expression of Ih in the proximity of the axon origin controls the integrative properties of nigral dopamine neurons.
Engel D; Seutin V
J Physiol; 2015 Nov; 593(22):4905-22. PubMed ID: 26350173
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological Characterization of Novel Effects of the Uptake-2 Blocker Decynium-22 (D-22) on Dopaminergic Neurons in the Substantia Nigra Pars Compacta.
Lloyd JT; Martini A; McDouall A; Sood R; Freestone PS; Mercuri NB; Lipski J
Neuroscience; 2019 Jan; 396():154-165. PubMed ID: 30447392
[TBL] [Abstract][Full Text] [Related]
9. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
Zhai A; Zhu X; Wang X; Chen R; Wang H
Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
[TBL] [Abstract][Full Text] [Related]
10. Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.
Choi SJ; Panhelainen A; Schmitz Y; Larsen KE; Kanter E; Wu M; Sulzer D; Mosharov EV
J Biol Chem; 2015 Mar; 290(11):6799-809. PubMed ID: 25596531
[TBL] [Abstract][Full Text] [Related]
11. Early postnatal development of substantia nigra neurons in rat midbrain slices: hyperpolarization-activated inward current and dopamine-activated current.
Washio H; Takigachi-Hayashi K; Konishi S
Neurosci Res; 1999 Jul; 34(2):91-101. PubMed ID: 10498335
[TBL] [Abstract][Full Text] [Related]
12. Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
Neurodegeneration; 1996 Sep; 5(3):265-74. PubMed ID: 8910905
[TBL] [Abstract][Full Text] [Related]
13. The effects of piroxicam in the attenuation of MPP+/MPTP toxicity in vitro and in vivo.
Soliman Y; Jackson T; Mazzio E; Soliman KF
Neurochem Res; 2009 Feb; 34(2):304-10. PubMed ID: 18612814
[TBL] [Abstract][Full Text] [Related]
14. Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.
Zawada WM; Banninger GP; Thornton J; Marriott B; Cantu D; Rachubinski AL; Das M; Griffin WS; Jones SM
J Neuroinflammation; 2011 Oct; 8():129. PubMed ID: 21975039
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro.
Iribe Y; Moore K; Pang KC; Tepper JM
J Neurophysiol; 1999 Aug; 82(2):925-33. PubMed ID: 10444687
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
[TBL] [Abstract][Full Text] [Related]
17. 1-Methyl-4-phenylpridinium (MPP+)-induced functional run-down of GABA(A) receptor-mediated currents in acutely dissociated dopaminergic neurons.
Wu J; Chan P; Schroeder KM; Ellsworth K; Partridge LD
J Neurochem; 2002 Oct; 83(1):87-99. PubMed ID: 12358732
[TBL] [Abstract][Full Text] [Related]
18. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation.
Obata T; Yamanaka Y; Kinemuchi H; Oreland L
Brain Res; 2001 Jul; 906(1-2):170-5. PubMed ID: 11430875
[TBL] [Abstract][Full Text] [Related]
19. Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones.
Wild AR; Akyol E; Brothwell SL; Kimkool P; Skepper JN; Gibb AJ; Jones S
Neuropharmacology; 2013 Oct; 73():138-46. PubMed ID: 23727219
[TBL] [Abstract][Full Text] [Related]
20. Tipepidine activates VTA dopamine neuron via inhibiting dopamine D₂ receptor-mediated inward rectifying K⁺ current.
Hamasaki R; Shirasaki T; Soeda F; Takahama K
Neuroscience; 2013 Nov; 252():24-34. PubMed ID: 23896570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
